Clinical trial Recruiting at 1 site Interventional Ages 16 and up

Comparing Latarjet and Modified Eden-Hybinette shoulder stabilization surgeries

Official title: Randomized Trial for the Treatment of Recurrent Anterior Dislocation of the Shoulder: Latarjet Versus Modified Eden-Hybinette

Run by University of Sao Paulo · NCT02913352 · Data updated 2026-11-12

This tests whether Latarjet or Modified Eden‑Hybinette surgery better prevents repeat anterior shoulder dislocations in people with recurrent traumatic dislocation and significant glenoid bone loss.

Quick facts

Study typeInterventional
Ages16 Years and up
SexAll
Enrollment60 (estimated)
SponsorUniversity of Sao Paulo
Academic / other
Locations1 site (São Paulo, São Paulo)
StatusRecruiting
StartedSeptember 1, 2016
Main results expectedDecember 1, 2027
Study endsDecember 1, 2029
Registry record updatedJanuary 29, 2026
Trial IDNCT02913352 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

People with recurrent traumatic anterior shoulder dislocation and anterior glenoid bone loss greater than 20%, or off‑track Hill‑Sachs lesions or recurrence after prior Bankart repair, are ideal candidates.

Probably not a fit

Patients with very large Hill‑Sachs defects (>40% of the humeral head), untreated seizures, multidirectional instability, complete rotator cuff tears, or advanced glenohumeral arthritis are unlikely to benefit or are excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, parallel 1:1 surgical trial at a single center comparing the Latarjet procedure to a modified Eden‑Hybinette bone graft with capsular repair for recurrent traumatic anterior glenohumeral dislocation. Eligible patients have recurrent dislocations with substantial anterior glenoid bone loss or off‑track Hill‑Sachs lesions, including failures after prior arthroscopic Bankart repair. The Latarjet offers a sling effect and historically low recurrence but has risks such as neurologic injury and graft resorption, while the Eden‑Hybinette restores glenoid surface without coracoid osteotomy but lacks the sling. Outcomes will focus on recurrence, graft healing/complications, and shoulder function to determine which approach gives better stability and fewer adverse events.

Why it matters

Potential benefit: If successful, the trial could identify which surgery gives better long‑term shoulder stability and fewer complications, helping surgeons choose the best option for patients with bone loss.

How similar studies have gone: Observational studies report low recurrence with Latarjet but notable complication and graft‑resorption rates, while Eden‑Hybinette data are limited and no prior randomized head‑to‑head comparisons have been published.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* History of one or more previous episodes of traumatic glenohumeral dislocation;
* Anterior glenoid bone loss superior to 20% of its diameter, regardless of the ISIS score;
* Recurrence of glenohumeral dislocation in cases previously treated with arthroscopic Bankart repair, regardless of the ISIS score and severity of bone lesion of the glenoid;
* Borderline bipolar bone lesions:
* Instability Severity Index Score of (ISIS) greater than or equal to 4 points, with anterior glenoid bone loss (bone Bankart lesion) greater than 13.5% of their diameter, measured by the method described by Sugaya et al.;
* Hill-Sachs lesion and glenoid considered "off-track".

Exclusion Criteria:

* Hill-Sachs lesion greater than 40% of the humeral head diameter (measured by the preoperative CT);
* Untreated seizures;
* Previously diagnosed rotator cuff complete tear;
* Fractures of the proximal humerus (except for Hill-Sachs lesions);
* Multidirectional instability;
* Advanced glenohumeral osteoarthritis (grade 3 Samilson and Pietro)

Where it's running

  • Instituto de Ortopedia e Traumatologia
    São Paulo, São Paulo, Brazil
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Sling vs Dynamic Shoulder Brace After Shoulder Stabilization

    This pilot randomized trial tests whether a dynamic shoulder orthosis helps people recover faster after arthroscopic stabilization for anterior shoulder instability compared with a standard sling.

    Recruiting Hospital Universitari de Bellvitge · L'Hospitalet de Llobregat, Catalonia · NCT07644624

  • Evaluating treatment options for first-time shoulder dislocation

    This study is testing whether a surgical option or a non-surgical approach works better for young people who have just dislocated their shoulder for the first time.

    Recruiting McMaster University · Hamilton, Ontario · NCT05715021

  • Comparing two surgical methods for shoulder dislocation treatment

    This study is testing which of two shoulder surgeries, the Latarjet procedure or Anatomic Glenoid Reconstruction, works better for people with significant bone loss after multiple dislocations.

    Recruiting Nova Scotia Health Authority · Halifax, Nova Scotia · NCT05658289

  • Comparing surgical methods for shoulder instability with bone loss

    This study tests which of three different shoulder surgeries works best for military and civilian patients with some bone loss, to help them recover faster and get back to their activities.

    Recruiting at 10 sites University of Pittsburgh · Tempe, Arizona and 14 other locations · NCT04809064

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.